Nebenwirkungen · Tagrisso
TAGRISSO 40 mg film-coated tablets TAGRISSO 80 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 13
HOS-135432 · Präparat HOS-097706
ILD or ILD-like adverse reactions were reported in 7.7% and were fatal in 0.7% (n=1) of the 143 patients who received TAGRISSO following definitive platinum-based chemoradiation therapy in LAURA. The incidence of ILD was 6.6% in patients of non-Japanese Asian ethnicity and 17.2% in non-Asian patients; no patients of Japanese ethnicity had an event of ILD. The median time from first dose to onset of ILD or ILD-like adverse reactions was 1.9 months. The median time from last dose of radiotherapy to onset of ILD or ILD-like adverse reactions was 3.0 months.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-18T16:00:00Z · SHA-256 36d1f10f3b323cac93ed4124915e050ad98541d8f140829a41c0c4e0ad3343cb · Passage fcee5a555411286a7c976ac5b61bd2300143e5129eaf75c1267c17a99b9b50c6 · Zeichen 12515–13075 im Abschnitt